Clinical evaluation of malignant transformation in oral leukoplakia
Fumihiko Tsushima(Johns Hopkins University), Ken Omura(Ebina General Hospital), Masaru Satô(Kazusa DNA Research Institute), Jinkyo Sakurai, Yuri SUDA(Tokyo Medical and Dental University), Hiroyuki Harada(Tokyo Medical and Dental University), Kae Tanaka(Tokyo Medical and Dental University), Hirofumi Tomioka, Yusuke Nakajima(Tokyo Medical and Dental University), Hiroaki Shimamoto(Tokyo Medical and Dental University)
Cited by 5
Related Papers
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
|Cancer Research|2008|618
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
|Blood|2010|323
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
|International Journal of Clinical Oncology|2014|263
The Tumor Suppressive MicroRNA <i>miR-218</i> Targets the mTOR Component <i>Rictor</i> and Inhibits AKT Phosphorylation in Oral Cancer
|Cancer Research|2011|250
Differential binding properties of B7-H1 and B7-DC to programmed death-1
|Biochemical and Biophysical Research Communications|2003|206